Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Status: Active
Phase: Phase II
Type: Prevention
Age: 50 to 80
Trial IDs: 13-000432, NCI-2014-01257, 13-000432-AM-00004, NCT02176902
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Status: Temporarily closed
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: INST 1211, NCI-2013-00443, NCT01821833
COGNUTRIN in Improving Thinking and Memory in Breast Cancer Survivors
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 45 to 75
Trial IDs: 17089, NCI-2014-00434, MCC-17089, NCT01823991
Omega-3 Fatty Acids in Preventing Recurrence in Patients with Hormone Receptor-Negative or HER2-Positive Stage 0-III Breast Cancer That Have Completed Treatment
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: OSU-13130/2013C0068, NCI-2014-02036, 2013C0068, OSU-13130, NCT02295059
Effect of Omega-3 Fatty Acid and/or Letrozole on Hormone Levels in Obese Patients with Newly Diagnosed Estrogen Receptor Positive Breast Cancer before Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CTMS 15-2100, NCI-2015-01534, 15-2100, HSC20150602H, NCT02538484
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients with Stage I-III Breast Cancer
Status: Not yet active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: OSU-15222, NCI-2016-00377, NCT02831582
Start Over